In Summary
AstraZeneca is in its 3rd week of a sell signal that the market has yet to confirm: three sideways closes, no bearish follow-through. Signal strength has dropped to 2 out of 100 — near absent — and the quality band flags trading as not recommended. A case to watch, not to trade.
Sell signal in observation
·3rd week from start
·EU-UK stocks
·T2
IQS Phase
75
in tension
Signal Strength
2
low · fading
Sizing
MINIMUM
Ranking
#44 / 57
EU-UK stocks sell signals
restricted Platinum content